Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis

Canadian Journal of Psychiatry

Volumn 55, Issue 3, 2010, Pages 165-171

  Dragt, Sara ^a   Nieman, Dorien H ^a   Becker, Hiske E ^a   Van De Fliert, Reinaud ^a   Dingemans, Peter M ^a   De Haan, Lieuwe ^a   Van Amelsvoort, Thérèse A ^a   Linszen, Don H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adolescence; Age of onset; Cannabis; Prodromal; Psychosis; Ultra high risk

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANNABIS ADDICTION; CHILD; CHRONOLOGY; DRUG USE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; ONSET AGE; PSYCHOSIS; RISK ASSESSMENT; SCHIZOPHRENIA; SCHOOL CHILD;

EID: 77950453195     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371005500308     Document Type: Article

References (31)

1. Abraham MD, Kaal HL, Cohen PDA. Licit and illicit drug use in Amsterdam, 1987 to 2001. Amsterdam (NL): CEDRO/Mets en Schilt; 2002.
2. Strang J, Witton J, Hall W. Improving the quality of the cannabis debate: defining the different domains. BMJ. 2000;320:108-110.
3. Arseneault L, Cannon M, Witton J, et al. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry. 2004;184:111-117.
4. Johns A. Psychiatric effects of cannabis. Br J Psychiatry. 2001;178:116-122.
5. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent onset schizophrenic disorders. Arch Gen Psychiatry. 1994;51:273-279.
6. Hall W, Solowij N. Adverse effects of cannabis. Lancet. 1998;352:1611-1616.
7. Veen ND, Selten JP, Van der Tweel I, et al. Cannabis use and age at onset of schizophrenia. Am J Psychiatry. 2004;161:501-506.
8. Murray RM, Morrison PD, Henquet C, et al. Cannabis, the mind and society: the hash realities. Nat Rev Neurosci. 2007;8:885-895.
9. Moore THM, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370:319-328.
10. Cornblatt B, Lencz T, Kane J. Treatment of the schizophrenia prodrome: is it presently ethical? Schizophr Res. 2001;52:31-38.
11. Cornblatt B, Lencz T, Obuchowski M. The schizophrenia prodrome: treatment and high-risk perspectives. Schizophr Res. 2002;54:177-186.
12. McGorry PD, MacFarlane C, Patton GC, et al. The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey. Acta Psychiatr Scand. 1995;92:241-249.
13. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophrenia Bull. 1996;22:353-370.
14. Yung AR, Philips LJ, Yuen HP, et al. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res. 2003;60:21-32.
15. Patton GC, Coffey C, Carlin JB, et al. Cannabis use and mental health in young people: cohort study. BMJ. 2002;325:1195-1198.
16. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;24:327-360.
17. Spitzer RL, Williams JB, Gibbon M, et al. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry. 1992;49(8):642-1629
18. Miller TJ, McGlashan TH, Lifshey Rosen J, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interpreter reliability and predictive validity. Am J Psychiatry. 2002;159:863-865.
19. Klosterkotter J, Hellmich M, Steinmeyer EM, et al. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58:158-164.
20. Andrews G, Peters L. The psychometric properties of the composite international diagnostic interview. Soc Psychiatry Psychr Epidemiol. 1998;33:80-88.
21. Häfner H, Riecher-Rössler A, Hambrecht M, et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res. 1992;6:209-223.
22. Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry. 2003;60:565-571.
23. Häfner H, Maurer K, Löffler W, et al. The influence of age and sex on the onset and early course of Schizophrenia. Br J Psychiatry. 1993;162:80-86.
24. Hall W, Degenhardt L, Teesson M. Cannabis use and psychotic disorders: an update. Drug Alcohol Rev. 2004;23:433-443.
25. Ferdinand RF, Sondeijker F, van der Ende J, et al. Cannabis use predicts future psychotic symptoms, and vice versa. Addiction. 2005;100:612-618.
26. Peralta V, Cuesta MJ. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr Scand. 1992;85:127-130.
27. Cleghorn JM, Kaplan RD, Szechtman H, et al. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. J Clin Psychiatry. 1991;52:26-30.
28. Negrete JC, Knapp WP, Douglas DE, et al. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol Med. 1986;16:512-520.
29. Wittchen HU, Burke JD, Semler G, et al. Recall and dating of psychiatric symptoms. Test-retest reliability of time-related symptom questions in a standardized psychiatric interview. Arch Gen Psychiatry. 1989;46:437-443.
30. Johnson TP, Mott JA. The reliability of self reported age of onset of tobacco, alcohol and illicit drug use. Addiction. 2001;96:1187-1198.
31. Brill N, Reichenberg A, Rabinowitz J, et al. Accuracy of self-reported premorbid functioning in schizophrenia. Schizophr Res. 2007;97:103-108.